Actavis Inc recalls Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories I…
- Recall date
- January 12, 2017
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0439-2017
- FDA classification
- Class III
- Brand / firm
- Actavis Inc
- Sold / distributed
- Nationwide in the US
Why it was recalled
Failed Impurities/Degradation Specifications: Product is out of specification for a known degradant.
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Albuterol Sulfate Inhalation Solution, USP, 0.021% (0.63 mg / 3 mL), 3mL Vials, Rx only, Mfd. for Watson Laboratories Inc., Corona, CA 92880 USA, Mfd. by Cipla Ltd. Verna, Goa India, NDC 0591-3467-53
Get recall alerts
Free email alert whenever Actavis Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Actavis Inc